We estimate that the CEO of BOSTON SCIENTIFIC CORP ($BSX), Michael F. Mahoney, received a compensation of $23,532,050 in 2025. This is an increase of 8.97% from an estimated $21,420,801 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 18, 2026. Note that parsing errors may occur.
You can track $BSX on Quiver Quantitative's $BSX stock dashboard.
$BSX Stock Insider Trading Activity
$BSX Stock insiders have traded $BSX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BSX stock by insiders over the last 6 months:
- MICHAEL F MAHONEY (Chairman, President & CEO) has made 0 purchases and 2 sales selling 160,901 shares for an estimated $15,043,394.
- JOSEPH MICHAEL FITZGERALD (EVP & Group Pres, Cardiology) has made 0 purchases and 5 sales selling 100,000 shares for an estimated $9,896,664.
- ELLEN M ZANE has made 0 purchases and 3 sales selling 25,782 shares for an estimated $2,573,877.
- ARTHUR C BUTCHER (EVP& Grp Pres, MedSurg & APAC) sold 17,313 shares for an estimated $1,758,188
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BSX Stock Government Contracts
We have seen $23,868,402 of award payments to $BSX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- THERASPHERE Y-90 GLASS MICROSPHERE MEDICATION: $1,260,000
- Y90 GLASS MICROSPHERES: $1,197,000
- Y90 THERASPHERE: $1,155,000
- VAPAHCS THERASPHERE Y90 RADIOPHARMACEUTICALS: $954,240
- THERASPHERE YTTIRUM-90 (Y-90) GLASS: $833,910
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$BSX Stock Congressional Stock Trading
Members of Congress have traded $BSX stock 12 times in the past 6 months. Of those trades, 6 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $BSX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 4 purchases worth up to $60,000 on 02/10, 01/30, 11/18, 10/17 and 1 sale worth up to $15,000 on 12/24.
- SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.
- SENATOR JOHN BOOZMAN sold up to $15,000 on 12/17.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 10/28.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$BSX Stock Hedge Fund Activity
We have seen 815 institutional investors add shares of $BSX Stock stock to their portfolio, and 939 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 32,976,583 shares (-75.1%) from their portfolio in Q4 2025, for an estimated $3,144,317,189
- BLACKROCK, INC. removed 9,188,624 shares (-6.3%) from their portfolio in Q4 2025, for an estimated $876,135,298
- BANK OF AMERICA CORP /DE/ removed 8,753,856 shares (-25.8%) from their portfolio in Q4 2025, for an estimated $834,680,169
- MARSHALL WACE, LLP removed 6,841,803 shares (-69.8%) from their portfolio in Q4 2025, for an estimated $652,365,916
- WELLINGTON MANAGEMENT GROUP LLP removed 4,944,352 shares (-33.7%) from their portfolio in Q4 2025, for an estimated $471,443,963
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 4,508,152 shares (+32.1%) to their portfolio in Q4 2025, for an estimated $429,852,293
- UBS GROUP AG added 4,304,984 shares (+40.7%) to their portfolio in Q4 2025, for an estimated $410,480,224
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BSX Stock Analyst Ratings
Wall Street analysts have issued reports on $BSX in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/05/2026
- Truist Securities issued a "Buy" rating on 02/05/2026
- BTIG issued a "Buy" rating on 02/04/2026
- RBC Capital issued a "Outperform" rating on 12/17/2025
- UBS issued a "Buy" rating on 10/23/2025
- Evercore ISI Group issued a "Outperform" rating on 10/07/2025
- Canaccord Genuity issued a "Buy" rating on 10/01/2025
To track analyst ratings and price targets for $BSX Stock, check out Quiver Quantitative's $BSX forecast page.
$BSX Stock Price Targets
Multiple analysts have issued price targets for $BSX recently. We have seen 18 analysts offer price targets for $BSX in the last 6 months, with a median target of $103.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $92.0 on 03/18/2026
- Danielle Antalffy from UBS set a target price of $105.0 on 03/17/2026
- Joanne Wuensch from Citigroup set a target price of $94.0 on 03/11/2026
- William Plovanic from Canaccord Genuity set a target price of $109.0 on 02/17/2026
- Marie Thibault from BTIG set a target price of $110.0 on 02/09/2026
- Mike Matson from Needham set a target price of $97.0 on 02/05/2026
- Joshua Jennings from TD Cowen set a target price of $100.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
